Addition of Local Hepatic Therapy to Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Stage BCLC C)

Publisher： Karger

E-ISSN： 1421-9867|90|4|219-228

ISSN： 0012-2823

Source： Digestion, Vol.90, Iss.4, 2014-12, pp. : 219-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis

By  

Digestion, Vol. 83, Iss. 4, 2011-02 ,pp. : 275-282

Karger

Access to resources Recommend Favorite

Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma

By Ogasawara Sadahisa  

Hepatology International, Vol. 5, Iss. 3, 2011-09 ,pp. : 850-856

Springer Publishing Company

Access to resources Recommend Favorite

Surgery Versus Transarterial Chemoembolization for Solitary Large Hepatocellular Carcinoma of BCLC Stage A

By Jin Young-Joo   Lee Jin-Woo   Choi Yong-Jun   Chung Hyun   Kim Young   Lee Kun-Young   Ahn Seung   Shin Woo   Cho Soon   Jeon Yong  

Journal of Gastrointestinal Surgery, Vol. 18, Iss. 3, 2014-03 ,pp. : 555-561

Springer Publishing Company

Access to resources Recommend Favorite

Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States

By  

Liver Cancer, Vol. 6, Iss. 3, 2017-04 ,pp. : 216-226

Karger

Access to resources Recommend Favorite

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 4, Iss. 4, 2015-0 ,pp. : 253-262

Karger

Access to resources Recommend Favorite